Anna Pagonakis

Array ( [id] => 6638442 [patent_doc_number] => 20100035977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'TWO-COMPONENT TAXANE CONTAINING PHARMACEUTICAL COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/522329 [patent_app_country] => US [patent_app_date] => 2007-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3544 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035977.pdf [firstpage_image] =>[orig_patent_app_number] => 12522329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4965822 [patent_doc_number] => 20080108642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Composition and its use as effective constituent of a medicine having anti-angiogenesis synergy effect' [patent_app_type] => utility [patent_app_number] => 11/975320 [patent_app_country] => US [patent_app_date] => 2007-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3437 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108642.pdf [firstpage_image] =>[orig_patent_app_number] => 11975320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586038 [patent_doc_number] => 20090105240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Methods for treating leukemia and myelodysplastic syndrome, and methods for identifying agents for treating same' [patent_app_type] => utility [patent_app_number] => 11/975082 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11062 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105240.pdf [firstpage_image] =>[orig_patent_app_number] => 11975082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932705 [patent_doc_number] => 08492405 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity' [patent_app_type] => utility [patent_app_number] => 12/311892 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29644 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12311892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 142037 [patent_doc_number] => 07687496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-30 [patent_title] => 'C7-substituted camptothecin analogs' [patent_app_type] => utility [patent_app_number] => 11/974754 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25712 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/687/07687496.pdf [firstpage_image] =>[orig_patent_app_number] => 11974754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5285491 [patent_doc_number] => 20090099166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'C10-substituted camptothecin analogs' [patent_app_type] => utility [patent_app_number] => 11/974756 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15309 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099166.pdf [firstpage_image] =>[orig_patent_app_number] => 11974756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527617 [patent_doc_number] => 08044209 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Pyrrolydine derivatives as IAP inhibitors' [patent_app_type] => utility [patent_app_number] => 12/445435 [patent_app_country] => US [patent_app_date] => 2007-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18592 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044209.pdf [firstpage_image] =>[orig_patent_app_number] => 12445435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825121 [patent_doc_number] => 20080124407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'INHIBITING CYP3A4 INDUCTION' [patent_app_type] => utility [patent_app_number] => 11/867299 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10614 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124407.pdf [firstpage_image] =>[orig_patent_app_number] => 11867299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4832979 [patent_doc_number] => 20080131526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'AKT SENSITIZATION OF CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 11/867394 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 4848 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20080131526.pdf [firstpage_image] =>[orig_patent_app_number] => 11867394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507794 [patent_doc_number] => 07915245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Methods and compositions of trail-death receptor agonists/activators' [patent_app_type] => utility [patent_app_number] => 11/866162 [patent_app_country] => US [patent_app_date] => 2007-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 68 [patent_no_of_words] => 30714 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915245.pdf [firstpage_image] =>[orig_patent_app_number] => 11866162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626649 [patent_doc_number] => 08796329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Method for controlling angiogenesis in animals' [patent_app_type] => utility [patent_app_number] => 11/906137 [patent_app_country] => US [patent_app_date] => 2007-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12663 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11906137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257885 [patent_doc_number] => 20100029743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'ATORVASTATIN PHARMACEUTICAL COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/443242 [patent_app_country] => US [patent_app_date] => 2007-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5372 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029743.pdf [firstpage_image] =>[orig_patent_app_number] => 12443242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629290 [patent_doc_number] => 20100004262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF ARIPIPRAZOLE' [patent_app_type] => utility [patent_app_number] => 12/443036 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22648 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004262.pdf [firstpage_image] =>[orig_patent_app_number] => 12443036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509230 [patent_doc_number] => 20090082437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Use of Oxaliplatin for Enhancing Radiosensitivity in Radiotherapy of Cervical Cancer' [patent_app_type] => utility [patent_app_number] => 11/861831 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3759 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082437.pdf [firstpage_image] =>[orig_patent_app_number] => 11861831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4786256 [patent_doc_number] => 20080139585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'SPECIFIC INHIBITORS FOR VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/859235 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8799 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0139/20080139585.pdf [firstpage_image] =>[orig_patent_app_number] => 11859235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273615 [patent_doc_number] => 08637547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases' [patent_app_type] => utility [patent_app_number] => 12/443096 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33705 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12443096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922665 [patent_doc_number] => 20080070982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'System and methods of melanoma prevention' [patent_app_type] => utility [patent_app_number] => 11/901056 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1807 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070982.pdf [firstpage_image] =>[orig_patent_app_number] => 11901056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495923 [patent_doc_number] => 20100093843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NOVEL NUTRACEUTICAL AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF CARTILAGE DEGRADATION OR CARTILAGE DAMAGE IN JOINTS' [patent_app_type] => utility [patent_app_number] => 12/438405 [patent_app_country] => US [patent_app_date] => 2007-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5310 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093843.pdf [firstpage_image] =>[orig_patent_app_number] => 12438405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6597413 [patent_doc_number] => 20100048657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'CONTROL OF MALIGNANT CELLS PROLIFERATION THROUGH THE INHIBITION OF CASEIN KINASE 2' [patent_app_type] => utility [patent_app_number] => 12/441077 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13797 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048657.pdf [firstpage_image] =>[orig_patent_app_number] => 12441077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685403 [patent_doc_number] => 20100120738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'ANTI-APOPTOTIC BENZODIAZEPINE RECEPTOR LIGAND INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/440719 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20169 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120738.pdf [firstpage_image] =>[orig_patent_app_number] => 12440719 [rel_patent_id] =>[rel_patent_doc_number] =>)